Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) EBT Margin (2016 - 2025)

Xtant Medical Holdings has reported EBT Margin over the past 16 years, most recently at 4.71% for Q3 2025.

  • Quarterly EBT Margin rose 2247.0% to 4.71% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.7% through Sep 2025, up 1649.0% year-over-year, with the annual reading at 13.87% for FY2024, 1273.0% down from the prior year.
  • EBT Margin was 4.71% for Q3 2025 at Xtant Medical Holdings, down from 10.75% in the prior quarter.
  • Over five years, EBT Margin peaked at 27.7% in Q3 2023 and troughed at 17.76% in Q3 2024.
  • The 5-year median for EBT Margin is 11.51% (2023), against an average of 7.44%.
  • Year-over-year, EBT Margin soared 4388bps in 2023 and then tumbled -4546bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 17.04% in 2021, then increased by 16bps to 14.33% in 2022, then increased by 7bps to 13.26% in 2023, then increased by 25bps to 9.98% in 2024, then surged by 147bps to 4.71% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's EBT Margin are 4.71% (Q3 2025), 10.75% (Q2 2025), and 0.1% (Q1 2025).